haloperidol has been researched along with adenosine in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (28.13) | 18.7374 |
| 1990's | 6 (18.75) | 18.2507 |
| 2000's | 7 (21.88) | 29.6817 |
| 2010's | 7 (21.88) | 24.3611 |
| 2020's | 3 (9.38) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Caporali, MG; Popoli, P; Scotti de Carolis, A | 1 |
| Fujiwara, Y; Kazahaya, Y; Otsuki, S; Sandyk, R; Takeda, T | 1 |
| Mott, J; Sherman, AD | 1 |
| Bridges, AJ; Bristol, JA; Bruns, RF; Downs, DA; Heffner, TG; Moos, WH; Szotek, DL; Trivedi, BK | 1 |
| Abbracchio, MP; Cattabeni, F; Colombo, F; Di Luca, M; Zaratin, P | 1 |
| Holloway, WR; Thor, DH | 1 |
| Pugsley, TA; Stewart, SF | 1 |
| de Mello, FG; de Mello, MC; Klein, WL; Paes de Carvalho, R; Ventura, AL | 1 |
| Brown, DR; Koltun, WA; Pickren, KS; von Essen, C; Zervas, NT | 1 |
| Ferré, S; Giménez-Llort, L; Martínez, E | 1 |
| Miras-Portugal, MT; Mora, F; Pintor, J; Porras, A | 1 |
| Ferré, S; Fuxe, K; Li, XM; Ogren, SO; Schwarcz, R; Snaprud, P | 1 |
| Kanda, T; Nakamura, J; Shimada, J; Shiozaki, S; Suzuki, F | 1 |
| Chopde, CT; Ghosh, AK; Mandhane, SN | 1 |
| Dorsa, DM; Ward, RP | 1 |
| Beilstein, MA; Chen, JF; Cuellar, B; Fink, JS; Grandy, DK; Hackett, E; Impagnatiello, F; Low, MJ; Moratalla, R; Ongini, E; Rubinstein, M; Schwarzschild, MA | 1 |
| Costentin, J; El Yacoubi, M; Vaugeois, JM | 1 |
| Bishnoi, M; Chopra, K; Kulkarni, SK | 1 |
| Akahane, A; Aoki, S; Iwashita, A; Matsuda, R; Matsuoka, N; Mihara, K; Mihara, T; Mitani, Y; Yamamoto, H; Yarimizu, J | 1 |
| Akhondzadeh, S; Boroumand, MA; Ghaleiha, A; Honarbakhsh, N; Jafarinia, M; Raznahan, M; Rezaei, F; Tabrizi, M | 1 |
| Jones-Cage, C; Stratford, TR; Wirtshafter, D | 1 |
| Bagrov, IaIu; Manusova, NB | 1 |
| Kehinde, AJ | 1 |
| Devine, E; Hasselfeld, K; Koene, R; McCullumsmith, RE; Moody, CL; O'Donovan, SM; Sullivan, C | 1 |
| Borroto-Escuela, DO; Carlsson, J; Ciruela, F; Crans, RAJ; Fores-Pons, R; Fuxe, K; Lopez-Cano, M; Narváez, M; Romero-Fernandez, W; Taura, JJ | 1 |
| Fisone, G; Gangarossa, G; Onimus, O; Valjent, E | 1 |
| Correa, M; Ecevitoglu, A; Edelstein, GA; Lindgren, H; Mombereau, C; Moore, A; Nicholas, C; Presby, RE; Rotolo, RA; Salamone, JD | 1 |
1 review(s) available for haloperidol and adenosine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for haloperidol and adenosine
| Article | Year |
|---|---|
Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trial.
Topics: Adenosine; Adenosine Deaminase; Adult; Chronic Disease; Clozapine; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Prospective Studies; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2011 |
30 other study(ies) available for haloperidol and adenosine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
The role of the purinergic system in the control of stereotypy: relationship to D-1/D-2 dopamine receptor activity.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Benzazepines; Caffeine; Carbamazepine; Dopamine Antagonists; Drug Interactions; Electroencephalography; Haloperidol; Male; Rabbits; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Purinergic; Stereotyped Behavior | 1989 |
Inhibitory effects of carbamazepine on clonidine-induced aggressive behavior in mice.
Topics: Adenosine; Aggression; Animals; Behavior, Animal; Caffeine; Carbamazepine; Clonidine; Haloperidol; Male; Mice; Prazosin; Receptors, Cell Surface; Yohimbine | 1988 |
Effects of glutaminase inhibition on release of endogenous glutamic acid.
Topics: 2-Chloroadenosine; Adenosine; Amygdala; Animals; Aspartic Acid; Diazooxonorleucine; Dopamine; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Glutaminase; Glycine; Haloperidol; In Vitro Techniques; Rats; Serotonin; Synaptosomes | 1986 |
N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity.
Topics: Adenosine; Animals; Antipsychotic Agents; Ataxia; Avoidance Learning; Dose-Response Relationship, Drug; Haloperidol; Motor Activity; Rats; Receptors, Purinergic; Structure-Activity Relationship; Thioridazine | 1987 |
Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase.
Topics: Adenosine; Adenylyl Cyclases; Animals; Antipsychotic Agents; Corpus Striatum; Dopamine; Haloperidol; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Substantia Nigra | 1987 |
Interactive effects of caffeine, 2-chloroadenosine and haloperidol on activity, social investigation and play fighting of juvenile rats.
Topics: 2-Chloroadenosine; Adenosine; Aggression; Animals; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Male; Motor Activity; Rats; Receptors, Cell Surface; Receptors, Purinergic; Social Behavior | 1985 |
Increase of rat serum prolactin by adenosine analogs and their blockade by the methylxanthine aminophylline.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); alpha-Methyltyrosine; Aminophylline; Animals; Bromocriptine; Corpus Striatum; Haloperidol; In Vitro Techniques; Levodopa; Male; Methyltyrosines; Phenylisopropyladenosine; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic | 1985 |
Regulation of dopamine- and adenosine-dependent adenylate cyclase systems of chicken embryo retina cells in culture.
Topics: Adenosine; Adenylyl Cyclases; Animals; Cells, Cultured; Chick Embryo; Chickens; Cyclic AMP; Darkness; Dopamine; Fluphenazine; Haloperidol; Kinetics; Receptors, Dopamine; Retina | 1982 |
Local cerebral blood flow in the dog during intravenous infusion of dopamine.
Topics: Adenosine; Animals; Apomorphine; Cerebral Arteries; Cerebrovascular Circulation; Dogs; Dopamine; Dopamine Antagonists; Haloperidol; Hypoxia; Infusions, Parenteral; Methysergide; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Vasoconstriction | 1980 |
Dopamine-independent and adenosine-dependent mechanisms involved in the effects of N-methyl-D-aspartate on motor activity in mice.
Topics: Adenosine; Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Dopamine Antagonists; Drug Interactions; Haloperidol; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Motor Activity; N-Methylaspartate; Reserpine; Theophylline | 1995 |
Dopamine receptor blockade inhibits the amphetamine-induced release of diadenosine polyphosphates, diadenosine tetraphosphate and diadenosine pentaphosphate, from neostriatum of the conscious rat.
Topics: Adenosine; Adenosine Monophosphate; Amphetamine; Animals; Corpus Striatum; Dinucleoside Phosphates; Dopamine Antagonists; Haloperidol; Male; Perfusion; Rats; Rats, Wistar | 1995 |
Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.
Topics: Adenosine; Animals; Antihypertensive Agents; Binding, Competitive; Dopamine D2 Receptor Antagonists; Haloperidol; Kinetics; Male; Membranes; Motor Activity; Neostriatum; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Purinergic P1; Salicylamides; Theophylline | 1994 |
KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.
Topics: Adenosine; Administration, Oral; Animals; Antihypertensive Agents; Benserazide; Catalepsy; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Levodopa; Male; Mice; Phenethylamines; Purinergic Antagonists; Xanthines | 1994 |
Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Catalepsy; Dopamine Antagonists; Haloperidol; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Scopolamine; Theobromine; Theophylline; Xanthines | 1997 |
Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration.
Topics: Adenosine; Animals; Antipsychotic Agents; Behavior, Animal; Caffeine; Catalepsy; Clozapine; Corpus Striatum; Cyclic AMP; Dopamine D2 Receptor Antagonists; Gene Expression Regulation; Genes, fos; GTP-Binding Protein alpha Subunits, Gs; Haloperidol; Nerve Tissue Proteins; Neurons; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, Purinergic P1; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Second Messenger Systems; Serotonin; Serotonin Antagonists; Theophylline | 1999 |
The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice.
Topics: Adenosine; Amphetamines; Animals; Caffeine; Catalepsy; Corpus Striatum; Dopamine Antagonists; Enkephalins; Gene Expression; Haloperidol; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Purinergic P1; RNA, Messenger | 2001 |
Adenosine A2A receptors and depression.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Caffeine; Depression; Disease Models, Animal; Dopamine Antagonists; Drug Interactions; Haloperidol; Mice; Mice, Knockout; Motor Activity; Neurotransmitter Agents; Parkinsonian Disorders; Purines; Pyrimidines; Receptor, Adenosine A2A; Triazines; Triazoles | 2003 |
Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Topics: Adenosine; Akathisia, Drug-Induced; Animals; Antioxidants; Behavior, Animal; Brain; Caffeine; Catalase; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Glutathione; Haloperidol; Lipid Peroxidation; Male; Mastication; Maze Learning; Motor Activity; Neurotransmitter Agents; Rats; Rats, Wistar; Receptors, Purinergic P1; Stereotyped Behavior; Superoxide Dismutase; Vasodilator Agents | 2006 |
Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Aminopyridines; Animals; CHO Cells; Cognition Disorders; Cricetinae; Cricetulus; Dopamine; Haloperidol; Humans; Male; Memory Disorders; Mice; Mice, Inbred C57BL; MPTP Poisoning; Phenethylamines; Piperazines; Rats; Rats, Inbred F344; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Scopolamine | 2007 |
Differential effects of the adenosine A₂A agonist CGS-21680 and haloperidol on food-reinforced fixed ratio responding in the rat.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Behavior, Animal; Conditioning, Operant; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Phenethylamines; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reward | 2012 |
[Effects of dopamine and adenosine on regulation of water-electrolyte exchange in Amoeba proteus].
Topics: Adenosine; Adenylyl Cyclases; Amoeba; Benzazepines; Biological Transport; Dideoxyadenosine; Dopamine; Dopamine D2 Receptor Antagonists; Haloperidol; Protein Kinase C; Protein Kinase Inhibitors; Receptors, Dopamine D2; Staurosporine; Vacuoles; Water-Electrolyte Balance | 2014 |
Functional Oil from Black Seed Differentially Inhibits Aldose-reductase and Ectonucleotidase Activities by Up-regulating Cellular Energy in Haloperidol-induced Hepatic Toxicity in Rat Liver.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Aldehyde Reductase; Animals; Chemical and Drug Induced Liver Injury; Energy Metabolism; GPI-Linked Proteins; Haloperidol; Liver; Male; Malondialdehyde; Phytochemicals; Plant Oils; Rats, Wistar; Seeds; Sorbitol; Up-Regulation | 2017 |
Cell-subtype-specific changes in adenosine pathways in schizophrenia.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Kinase; Adenosine Triphosphatases; Adult; Aged; Animals; Antipsychotic Agents; Astrocytes; Equilibrative Nucleoside Transporter 1; Female; Frontal Lobe; Gene Expression; GPI-Linked Proteins; Haloperidol; Humans; Male; Middle Aged; Pyramidal Cells; Rats, Sprague-Dawley; Receptors, Purinergic P1; RNA, Messenger; Schizophrenia; Young Adult | 2018 |
The mGlu
Topics: Adenosine; Animals; Catalepsy; Dopamine; Haloperidol; HEK293 Cells; Humans; Mice; Parkinson Disease; Protein Subunits; Rats; Receptor, Adenosine A2A; Receptors, Dopamine D2 | 2022 |
Haloperidol-Induced Immediate Early Genes in Striatopallidal Neurons Requires the Converging Action of cAMP/PKA/DARPP-32 and mTOR Pathways.
Topics: Adenosine; Animals; Antipsychotic Agents; Corpus Striatum; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Genes, Immediate-Early; Glutamates; Haloperidol; Mice; Mice, Transgenic; N-Methylaspartate; Neurons; Receptors, Dopamine D1; TOR Serine-Threonine Kinases | 2022 |
Effort-related effects of chronic administration of the DA D
Topics: Adenosine; Animals; Antipsychotic Agents; Haloperidol; Purines; Rats | 2023 |